Prolonged hypocalcemia after zoledronic acid in a patient with metastatic prostate carcinoma: did zoledronic acid trigger osteoblastic activity and avid calcium uptake?

Clin Genitourin Cancer. 2012 Mar;10(1):50-3. doi: 10.1016/j.clgc.2011.11.004. Epub 2012 Jan 14.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Bone Density Conservation Agents / adverse effects*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / secondary
  • Calcium / metabolism*
  • Diphosphonates / adverse effects*
  • Humans
  • Hypocalcemia / chemically induced*
  • Imidazoles / adverse effects*
  • Male
  • Osteoblasts / drug effects*
  • Osteoblasts / pathology
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / pathology
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
  • Calcium